Summary
In a significant market movement during January 2026, QV Bioelectronics was the subject of a vc funding. The transaction achieved a gross valuation of £4,500,000. Leading the round was Bruntwood SciTech, Greater Manchester Combined Authority (GMCA), GMC Life Sciences Fund, Empirical Ventures, NPIF II – PXN Equity Finance, National Institute for Health and Care Research, PXN Ventures, Enterprise Cheshire and Warrington, Northern Powerhouse Investment Fund II (NPIF II), Innovate UK, PXN Ventures.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Bruntwood SciTech
Lead Investor / Acquirer
Greater Manchester Combined Authority (GMCA)
Lead Investor / Acquirer
GMC Life Sciences Fund
Lead Investor / Acquirer
Empirical Ventures
Lead Investor / Acquirer
NPIF II – PXN Equity Finance
Lead Investor / Acquirer
National Institute for Health
Lead Investor / Acquirer
Care Research
Lead Investor / Acquirer
PXN Ventures
Lead Investor / Acquirer
Enterprise Cheshire
Lead Investor / Acquirer
Warrington
Lead Investor / Acquirer
Northern Powerhouse Investment Fund II (NPIF II)
Lead Investor / Acquirer
Innovate UK
Lead Investor / Acquirer
PXN Ventures
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in